Cingulate CING
NASDAQ CING
$5.26 +0.03 (+0.48%)
As of: Sep 22, 2026 · 11:16 AM EDT

Cingulate (CING) Cash from Operations (2021 - 2025)

Cingulate's (CING) quarterly Cash from Operations came in at -$3.6 million in Q4 2025, up 11.82% on a YoY basis from -$3.2 million in Q4 2024, and up 15.25% quarter-over-quarter from -$4.2 million in Q3 2025.

Analysis

Cingulate (CING) Cash from Operations (2021 - 2025) Analysis & Trends

Cingulate (CING) has reported Cash from Operations for 5 consecutive years, with -$3.6 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations rose 11.82% year-over-year to -$3.6 million; the trailing twelve-month figure through Dec 2025 stood at -$17.2 million (up 6.54% YoY), and the FY2025 full-year result was -$17.2 million, up 6.54% from the prior year.
  • Cash from Operations grew to -$3.6 million in Q4 2025 per CING's latest filing, from -$4.2 million in the prior quarter.
  • Across five years, Cash from Operations topped out at -$1.6 million in Q2 2021 and bottomed at -$8.7 million in Q1 2024.
  • Historically, Cash from Operations has averaged -$3.9 million across 5 years, with a median of -$4.0 million in 2024.
  • The sharpest annual moves came in 2022 and 2024: Cash from Operations slumped 184.53% in 2022, then jumped 62.16% in 2024.
  • Over 5 years, Cash from Operations stood at -$4.6 million in 2021, then rose by 9.0% to -$4.2 million in 2022, then jumped by 39.09% to -$2.6 million in 2023, then sank by 59.21% to -$4.1 million in 2024, then advanced by 11.82% to -$3.6 million in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods registered -$3.6 million, -$4.2 million, and -$4.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn 8.62 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn 3.44 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn 5.37 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn 5.88 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn 835.00 Mn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn 3.39 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn 3.44 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn - -387.32 Mn
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn 462.82 Mn
10 Cingulate 72.81 Mn 72.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -3.60 Mn
Sep 30, 2025 -4.24 Mn
Jun 30, 2025 -4.80 Mn
Mar 31, 2025 -4.61 Mn
Dec 31, 2024 -4.08 Mn
Sep 30, 2024 -3.88 Mn
Jun 30, 2024 -1.74 Mn
Mar 31, 2024 -8.75 Mn
Dec 31, 2023 -2.56 Mn
Sep 30, 2023 -4.29 Mn
Jun 30, 2023 -4.60 Mn
Mar 31, 2023 -3.58 Mn
Dec 31, 2022 -4.21 Mn
Sep 30, 2022 -3.40 Mn
Jun 30, 2022 -4.41 Mn
Mar 31, 2022 -3.86 Mn
Dec 31, 2021 -4.62 Mn
Sep 30, 2021 -2.59 Mn
Jun 30, 2021 -1.55 Mn
Mar 31, 2021 -1.67 Mn
API Access

Cingulate Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=CING&period=max&api_key=YOUR_API_KEY